Flunisolide Nasal Solution
Asthma Drug Takes the Itch Out of Chronic Hives »
"Feb. 25, 2013 (San Antonio, Texas) -- The asthma drug Xolair appears to be a safe and effective treatment for chronic hives, a new study shows.
The results of the study were presented at a news conference here at the American Academy"...
Read the Asthma Drug Takes the Itch Out of Chronic Hives article »
Flunisolide Nasal Solution
SIDE EFFECTS
The adverse events rates listed below are based on symptoms spontaneously reported in multidose controlled clinical trials in comparing flunisolide nasal solution (29 mcg per spray) and flunisolide nasal solution (flunisolide nasal spray .025%) (25 mcg per spray) for treatment of allergic rhinitis. In patients receiving flunisolide nasal solution (flunisolide nasal spray .025%) the most common adverse events were transient aftertaste (17%) and transient nasal burning and stinging (13%). These symptoms did not usually interfere with treatment.
Adverse Event Rates for Flunisolide Nasal Solution (flunisolide nasal spray .025%) (29 mcg per spray)
Incidence Greater than 1% (probably casually related)
Respiratory: Nasal burning/stinging (13%), epistaxis*, nasal dryness, pharyngitis, cough increased
Gastrointestinal: Nausea
Special Senses: Aftertaste (17%)
Incidence 1% or Less (probably casually related)
Respiratory: Hoarseness
Special Senses: Abnormal sense of smell
Incidence 1% or Less (casual relationship unknown)+
Respiratory: Sinusitis
Adverse Event Rates for Flunisolide Nasal Solution (flunisolide nasal spray .025%) (25 mcg per spray)
Incidence Greater than 1% (probably casually related)
Respiratory: Nasal burning/stinging (44%), epistaxis*, nasal dryness*, pharyngitis*, cough increased
Gastrointestinal: Nausea
Special Senses: Aftertaste (8%)
Incidence 1% or Less (probably casually related)
Respiratory: Hoarseness, nasal ulcer
Incidence 1% or Less (casual relationship unknown)+
Respiratory: Sinusitis
* Incidence of reported reaction between 3% and 9%. Those reactions occurring
in less than 3% of the patients are unmarked.
+ Reactions occurred under circumstances where the casual relationship has not
been clearly established; they are presented as alerting information for physicians.
Cases of growth suppression have been reported for intranasal corticosteroids (including flunisolide nasal solution) (see PRECAUTIONS, Pediatric Use section).
Read the Flunisolide Nasal Solution (flunisolide nasal spray .025%) Side Effects Center for a complete guide to possible side effects »
DRUG INTERACTIONS
No information provided.
Last reviewed on RxList: 12/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Flunisolide Nasal Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.
Updated & New
